Greenwood Village, CO, March 06, 2024 –– Safe Rx® today named Lon von Hurwitz as its Market Access and Policy Director.
Mr. von Hurwitz has broad experience in both non-profit and enterprise level work, with a proven track record in pharmacy, healthcare, and health policy. Mr. von Hurwitz served in various prior roles at GE Healthcare, New Care Diabetes Ventures, Lifeclinic International and World Health Networks, and as National Chairman of Mothers Against Drunk Driving (MADD).
At Safe Rx, Mr. von Hurwitz will be responsible for market access growth, efficacy data development, and related activities.
“Lon’s expertise in mission driven healthcare and pharmacy work will help prepare us for significant market access growth with payors and self-insured plan sponsors,” said Milton Cohen, Safe Rx President and CEO.
The Company’s award-winning and market-leading locking prescription vial (LPV®) product line is used by pharmacies for controlled substance dispensing, and is a key solution for the opioid epidemic, with applications in both prevention and treatment.
“I’m excited to join the team at Safe Rx and help bring such a compelling intervention to policymakers, payors and plan sponsors,” said Mr. von Hurwitz. “We are at an inflection point for reimbursement growth, and clinicians and patients everywhere are in desperate need of our solution,” he added.